Case Report: Glofitamab and intrathecal rituximab combined with ICE chemotherapy for early isolated central nervous system relapse in pediatric Burkitt lymphoma: rapid clearance and successful bridging to autologous stem cell transplantation
BackgroundCentral nervous system (CNS) relapse is an uncommon and highly aggressive event in pediatric Burkitt lymphoma (BL), particularly when occurring early with parenchymal involvement. Despite CNS-directed chemotherapy, rapid and durable disease c…